# Exploratory Study of OPC-12759 Ophthalmic Suspension

> **NCT01493180** · PHASE2 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 102 (actual)

## Conditions studied

- Keratoconjunctival Epithelial Disorder

## Interventions

- **DRUG:** OPC-12759 ophthalmic suspension
- **DRUG:** Sodium hyaluronate ophthalmic solution

## Key facts

- **NCT ID:** NCT01493180
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-11
- **Final completion:** 2012-12
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2015-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01493180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01493180, "Exploratory Study of OPC-12759 Ophthalmic Suspension". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01493180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*